Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study

Ophthalmology
Kouros Nouri-MahdaviAdvanced Glaucoma Intervention Study

Abstract

To investigate the risk factors associated with visual field (VF) progression in the Advanced Glaucoma Intervention Study (AGIS) with pointwise linear regression (PLR) analysis of serial VFs. Prospective, multicenter, randomized clinical trial. Five hundred nine eyes of 401 patients from the AGIS with a baseline VF score of <or=16, >or=7 VF examinations, and >or=3 years of follow-up were selected. Visual field progression. This is a cohort study of patients enrolled in a prospective randomized clinical trial (AGIS). Worsening of a test location on PLR analysis was defined as a change of threshold sensitivity of >or=1.00 decibels a year, with P<or=0.01. Visual field progression was defined as worsening of at least 2 test locations within a Glaucoma Hemifield Test cluster with PLR analysis. Multivariate logistic regression was used to determine risk factors associated with VF worsening. Intraocular pressure (IOP) fluctuation was defined as standard deviation of the IOP at all visits after the initial surgery. The mean (+/- standard deviation) follow-up time and baseline AGIS score were 7.4 (+/-1.7) years and 7.7 (+/-4.4), respectively. Visual field progression was detected with PLR analysis in 151 eyes (30%). Older age at the ini...Continue Reading

References

Aug 1, 1977·Archives of Ophthalmology·E B WernerM Schulzer
Aug 1, 1991·The British Journal of Ophthalmology·B N NoureddinR A Hitchings
Jan 1, 1990·The British Journal of Ophthalmology·R VogelC J Bulpitt
Sep 1, 1982·Ophthalmology·W M Grant, J F Burke
Aug 15, 1993·American Journal of Ophthalmology·W C StewartG Sethuraman
Jun 1, 1997·Ophthalmology·J KatzA Sommer
Jun 24, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Y SuzukiC Hamada
Mar 8, 2000·American Journal of Ophthalmology·C Martínez-BellóR P LeBlanc
Oct 6, 2000·American Journal of Ophthalmology·W C StewartJ B Cantrell
Jun 1, 2001·American Journal of Ophthalmology·S DranceUNKNOWN Collaborative Normal-Tension Glaucoma Study Group
Apr 26, 2002·The British Journal of Ophthalmology·S K Gardiner, D P Crabb
Jul 18, 2002·Clinical & Experimental Ophthalmology·John LandersStuart L Graham
Jan 14, 2003·Archives of Ophthalmology·M Cristina LeskeUNKNOWN Early Manifest Glaucoma Trial Group
Aug 27, 2003·Investigative Ophthalmology & Visual Science·Eija VestiBalwantray C Chauhan

❮ Previous
Next ❯

Citations

Nov 1, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J Wahl
Dec 18, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A G M JünemannR Rejdak
Mar 10, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Boel Bengtsson, Anders Heijl
Feb 5, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Asan KochkorovSelim Orgul
Apr 16, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Brian L VanderBeekNathan M Radcliffe
Feb 11, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Akira Sawada, Tetsuya Yamamoto
Sep 16, 2008·Eye·R A Hitchings
Nov 29, 2005·Eye·D Vaideanu, S Fraser
Sep 7, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Viney GuptaRamanjit Sihota
Nov 16, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Samin HongGong Je Seong
Jul 1, 2006·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Mei-Ju ChenWen-Ming Hsu
Sep 7, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Geoffrey R OwenStella M Robertson
Mar 21, 2009·The American Journal of Nursing·Nancy C Sharts-Hopko, Catherine Glynn-Milley
Feb 26, 2009·Current Opinion in Ophthalmology·Harmohina BaggaRobert N Weinreb
Mar 3, 2009·Current Opinion in Ophthalmology·Kuldev Singh, Anurag Shrivastava
Jun 16, 2007·Journal of Glaucoma·Michael V Boland, Harry A Quigley
Mar 18, 2008·Journal of Glaucoma·Sameh MosaedRobert N Weinreb
Oct 16, 2008·Journal of Glaucoma·Christopher A GirkinFelipe A Medeiros
Jun 16, 2009·Journal of Glaucoma·Kwan Soo KimHae Ran Chang
Oct 27, 2009·Journal of Glaucoma·Paul P LeeUNKNOWN IOP Consensus Panel
Sep 1, 2011·Journal of Glaucoma·Minna NgLyne Racette
Mar 26, 2013·Journal of Glaucoma·Katrin LorenzNorbert Pfeiffer
Aug 21, 2010·Ophthalmic Plastic and Reconstructive Surgery·Michael S LeeFrank A Sloan
Jun 4, 2008·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Balwantray C Chauhan
Oct 23, 2010·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Stuart K GardinerChris A Johnson
Sep 14, 2011·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Stuart K GardinerShaban Demirel
Feb 7, 2012·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Daryl R Tabrett, Keziah Latham
Jul 19, 2005·The British Journal of Ophthalmology·B C ChauhanM T Nicolela
Dec 20, 2005·The British Journal of Ophthalmology·I StalmansT Zeyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.